Evidence map›Paper›PMID 34066537›Full record

ReviewViruses2021

Inflammasome, the Constitutive Heterochromatin Machinery, and Replication of an Oncogenic Herpesvirus.

Sumita Bhaduri-McIntosh, Michael T McIntosh

Open access · goldAbstract readReview
In one paragraph

Review in Viruses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Chromatin Control of EBV Infection and Latency.Current topics in microbiology and immunology · 2025
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Sumita Bhaduri-McIntoshDivision of Infectious Disease, Department of Pediatrics, University of Florida, Gainesville, FL 32610, USA.ORCID 0000-0003-2946-9497
Michael T McIntoshDepartment of Molecular Genetics and Microbiology, University of Florida, Gainesville, FL 32610, USA.ORCID 0000-0001-5798-3050
University of Florida · US

Funding

Host determinants of Epstein-Barr virus lytic cycle activationR01AI113134 · NIAID · UNIVERSITY OF FLORIDA · PI BHADURI-MCINTOSH, SUMITA · 2014 to 2018
$1.9M
sxRNA-based Antiviral Approach targeting Epstein-Barr virusR41AI115834 · NIAID · HOCUSLOCUS, INC. · PI BHADURI-MCINTOSH, SUMITA · 2015 to 2015
$225k
NIAID NIH HHS R01 AI113134NIAID NIH HHS R41 AI115834
6 · The paper itself

Abstract

The success of long-term host-virus partnerships is predicated on the ability of the host to limit the destructive potential of the virus and the virus's skill in manipulating its host to persist undetected yet replicate efficiently when needed. By mastering such skills, herpesviruses persist silently in their hosts, though perturbations in this host-virus equilibrium can result in disease. The heterochromatin machinery that tightly regulates endogenous retroviral elements and pericentromeric repeats also silences invading genomes of alpha-, beta-, and gammaherpesviruses. That said, how these viruses disrupt this constitutive heterochromatin machinery to replicate and spread, particularly in response to disparate lytic triggers, is unclear. Here, we review how the cancer-causing gammaherpesvirus Epstein-Barr virus (EBV) uses the inflammasome as a security system to alert itself of threats to its cellular home as well as to flip the virus-encoded lytic switch, allowing it to replicate and escape in response to a variety of lytic triggers. EBV provides the first example of an infectious agent able to actively exploit the inflammasome to spark its replication. Revealing an unexpected link between the inflammasome and the epigenome, this further brings insights into how the heterochromatin machinery uses differential strategies to maintain the integrity of the cellular genome whilst guarding against invading pathogens. These recent insights into EBV biology and host-viral epigenetic regulation ultimately point to the NLRP3 inflammasome as an attractive target to thwart herpesvirus reactivation.

Indexed as

CarcinogenesisCell Line, TumorEpigenesis, GeneticEpstein-Barr Virus InfectionsHerpesviridaeHerpesvirus 4, HumanHeterochromatinHumansInflammasomesVirus ActivationVirus LatencyVirus ReplicationHeterochromatinInflammasomesATMcaspase 1constitutive heterochromatinepigeneticsepigenomeEpstein–Barr virusgammaherpesvirusherpesvirusheterochromatininflammasomeKAP1KRAB–ZFPlytic phaselytic switchNLRP3reactivationTIF1βTRIM28viral protein kinaseZEBRA

Identifiers

PMID34066537
PMCPMC8148530
OpenAlexW3157273102

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.